Clinical trial
Nasonex Compared With Placebo in Participants With Seasonal Allergic Rhinitis…
NCT00070707 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00070707 |
|---|---|
| Title | Nasonex Compared With Placebo in Participants With Seasonal Allergic Rhinitis (SAR) and Concomitant Asthma (P03280) |
| Official title | Efficacy and Safety of Nasonex vs. Placebo in Subjects With SAR and Concomitant Asthma |
| Lead sponsor | Organon and Co, Industry |
| Collaborators | Integrated Therapeutics Group Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Rhinitis, Allergic, Seasonal, Asthma |
| Intervention type | Drug |
| Interventions | Mometasone, Placebo, Albuterol/Salbutamol |
| Enrollment | 188 |
| Start date | Apr 3, 2003 |
| Primary completion | Nov 26, 2003 |
| Completion | Nov 26, 2003 |
| First posted | Oct 10, 2003 |
| Last update posted | Sep 5, 2024 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: